There have been reports of Type llla and lllb endoleaks related to the company’s AFX Endovascular AAA Systems.
There is a risk that the delivery wire could break or separate during use, being left inside the patient’s bloodstream as a result.
In the United States, the company has recalled nearly 360,000 AirLife Resuscitation Device and Broselow Convenience Kits due to a malfunction risk.
The issue causes interference in the accuracy of the test method.
The company’s ED-3490TK duodenoscopes require replacement of the forceps elevator mechanism and other parts.
A manufacturing error could cause chamber parts to split into layers and cause water to back up into the patient breathing circuit.
The Class I recall is a result of a mold overflow defect that could obstruct blood flow.
The corrective action is intended to reduce the risk of patient harm as a result of cybersecurity vulnerabilities in the products.
In the United States, nearly 4500 devices will be relabeled and 500 devices removed due to the risk of thrombus formation in the device.
This offending company has “significant” violations regarding reporting corrections and removals to FDA.